← Back to Search

Using e-Nose Technology to Identify Early Lung Cancer

Uniondale, NY

N/A

Waitlist Available

Led By Gaetano Rocco, MD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 month (time to biopsy)

Awards & highlights

No Placebo-Only Group

Summary

This trial uses an electronic nose to detect early-stage lung cancer and see if bigger tumors are easier to diagnose.

See full description

Eligible Conditions

Lung Nodules
Lung Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 month (time to biopsy)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 month (time to biopsy)

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month (time to biopsy) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Disease status determined by e-nose testing

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Participants with an Undiagnosed Pulmonary NoduleExperimental Treatment1 Intervention

One hundred evaluable individuals aged 21 to 85 years with a single undiagnosed pulmonary nodule measuring \<3 cm, clinically staged as cT1N0M0 (eighth edition of the TNM staging manual) by CT and PET scans, will be enrolled in this diagnostic study and will undergo e-nose testing. These patients must have a risk assessment profile that, according to institutional guidelines, identifies them as candidates for subsequent surgical resection of the pulmonary nodule, which will confirm the results of the breathprinting analysis.

Do I qualify?Apply below to find out